← Leaderboards
Peter D. Cole
Albert Einstein College Of Medicine
$5,736,884
Attributed
$11,287,375
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2014–25$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,287,375 · 5
By mechanism
R01$10,875,315 · 4
R21$412,060 · 1
Top collaborators
- Stephen Alan Sands7 shared
- Elyse S Sussman5 shared
- Mark E Wagshul5 shared
- Mi-Hyeon Jang2 shared
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Elyse S Sussman$9,091,280
- Mark E Wagshul$1,530,468
- Jelena Pavlovi$1,944,190
Others in their field
Top investigators on “Impaired Cognition”
- Michael W Weiner · Northern California Institute Res &Educ$154,600,259
- Paul S. Aisen · Cognition Therapeutics, Inc.$147,845,108
- Randall J Bateman · Washington University$143,423,124
- David A Bennett · Rush University Medical Center$100,504,767
- Reisa A. Sperling · Banner Health$99,367,151
- Eric Martin McDade · Washington University$94,632,845
Research focus
Impaired CognitionCancer TherapyCognitive DeficitsCognitive FunctionQuality Of LifeNeurotoxicityClinical TrialsPreventBrainChildSchoolsFunctional DisorderSurvivorsMemoryImpairmentChemotherapyAcute Lymphocytic LeukemiaBiological MarkersCurative TreatmentsAttentionMalignant Childhood NeoplasmChildhood Acute Lymphocytic LeukemiaFoundationsChildhood Leukemia
Grant awards (20)
Identification of novel biomarkers and therapeutic strategies in chemobrain.$593,672
R01 · FY2025 · CA
Characterization of brain dysfunction during development in survivors of childhood acute lymphoblastic leukemia$844,664
R01 · FY2024 · CA
Identification of novel biomarkers and therapeutic strategies in chemobrain.$593,617
R01 · FY2024 · CA
Characterization of brain dysfunction during development in survivors of childhood acute lymphoblastic leukemia$925,510
R01 · FY2023 · CA
Characterization of brain dysfunction during development in survivors of childhood acute lymphoblastic leukemia$937,915
R01 · FY2022 · CA
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL$666,287
R01 · FY2022 · CA · contact PI
Characterization of brain dysfunction during development in survivors of childhood acute lymphoblastic leukemia$949,119
R01 · FY2021 · CA
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL$682,392
R01 · FY2021 · CA · contact PI
Characterization of brain dysfunction during development in survivors of childhood acute lymphoblastic leukemia$931,687
R01 · FY2020 · CA
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL$679,885
R01 · FY2020 · CA · contact PI
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL$659,113
R01 · FY2019 · CA · contact PI
Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL$695,429
R01 · FY2018 · CA · contact PI
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats$329,925
R01 · FY2018 · CA · contact PI
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats$346,525
R01 · FY2017 · CA · contact PI
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats$346,525
R01 · FY2016 · CA · contact PI
Markers of Cognitive Decline During Treatment for Childhood ALL$215,938
R21 · FY2016 · CA · contact PI
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats$262,856
R01 · FY2015 · CA · contact PI
Markers of Cognitive Decline During Treatment for Childhood ALL$196,122
R21 · FY2015 · CA · contact PI
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats$83,669
R01 · FY2015 · CA · contact PI
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats$346,525
R01 · FY2014 · CA · contact PI